Nathalie Bonnefoy, cofounder of OREGA Biotech and deputy director of Institut de Recherche en Cancérologie de Montpellier (IRCM), will inaugurate the first CyTOF Hyperion in France on September 18, 2019 at IRCM. Equipped with a very innovative technology, the CyTOF Hyperion will make it possible to explore tumor heterogeneity from a biopsy by very finely mapping tumor cells in their microenvironment, including the interactions with and between the immune cells. The CyTOF is a powerful tool for immuno-oncology studies. It reveals the structure of disease tissue at the single cell level and enables the characterization with up to 50 markers, from a single slide, of the spatial distribution and the cellular network with immune cells.

17 September 2019

Dr Bonnefoy to inaugurate first CyTOF Hyperion in France
17 September 2019

Nathalie Bonnefoy, cofounder of OREGA Biotech and deputy director of Institut de Recherche en Cancérologie de Montpellier (IRCM), will inaugurate the first CyTOF Hyperion in France on September 18, 2019 at IRCM. Equipped with a very innovative technology, the CyTOF Hyperion will make it possible to explore tumor heterogeneity from a biopsy by very finely mapping tumor cells in their microenvironment, including the interactions with and between the immune cells. The CyTOF is a powerful tool for immuno-oncology studies. It reveals the structure of disease tissue at the single cell level and enables the characterization with up to 50 markers, from a single slide, of the spatial distribution and the cellular network with immune cells.
[ Read more ]
27 July 2019

Anti-CD39 mAb publication in Cell Reports
27 July 2019

The publication of preclinical data of the CD39-blocking monoclonal antibody IPH5201 appears in the May 21, 2019 issue of the journal Cell Reports.  Read the full manuscript titled “Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies”
[ Read more ]
17 June 2019

Meet us at the 2019 ASCO annual meeting in Chicago
17 June 2019

Jeremy BASTID, Chief Operating Officer, will attend the ASCO annual meeting to be held in Chicago, IL, May 31 – June 4, 2019.
[ Read more ]
17 November 2018

Meet us at the 2018 Bio Europe meeting in Copenhagen
17 November 2018

Gilles Alberici, CEO, will attend the 2018 BIO-Europe meeting to be held in Copenhagen on November 2018, 5th to 7th.
[ Read more ]